From plaque biology to clinical setting

E. Arbustini, P. Morbini, B. Dal Bello, F. Prati, G. Specchia

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Coronary atherosclerosis may cause acute and chronic ischemic syndromes; the former are caused by 'acute plaque events,' mostly thrombosis complicating vulnerable ruptured plaques, namely severe lesions with large core, thin cap, and weak shoulder infiltrated by activated inflammatory cells. Plaque rupture may also occur in nonischemic settings and is not obligatorily complicated by thrombosis. Furthermore, plaque rupture is not the only thrombus substrate in acute ischemic syndromes: Superficial erosion of fibrous plaques is found in 44% of acute thrombi in sudden coronary deaths and in 25% of those in acute myocardial infarctions. Coronary thrombosis appears to be triggered by superficial intimal inflammation in plaque ulceration and by neointimal hyperplasia in plaque erosion. 'Endogenous' and, recently, exogenous factors, particularly infective intracellUlar organisms, have been proposed as major contributors to plaque inflammation, activation, and vulnerability. Possible exogenous triggers are DNA and RNA viruses and intracellular bacteria such as Chlamydia pneumoniae, which has been identified with microbiological, ultrastructural, immunohistochemical, and molecular tools in a consistent proportion of human plaque samples. Chlamydia increases local thrombogenicity and is associated with an atherogenic lipid profile. Systemic indexes of inflammation, such as PCR, SAA, and fibrinogen, are also increased in acute syndromes and common infectious diseases with high morbidity and minimal clinical impact are good candidates; Helicobacter pylori is a major one. Infectious agents could link local and systemic inflammation: White cells infected in its target tissue could circulate into the flow and be captured, on a specific local trigger, into vessel walls thus stimulating local inflammation.

Original languageEnglish
JournalAmerican Heart Journal
Volume138
Issue number2 II
DOIs
Publication statusPublished - 1999

Fingerprint

Inflammation
Thrombosis
Rupture
Tunica Intima
Coronary Thrombosis
Chlamydophila pneumoniae
DNA Viruses
Chlamydia
RNA Viruses
Sudden Death
Helicobacter pylori
Fibrinogen
Hyperplasia
Communicable Diseases
Coronary Artery Disease
Myocardial Infarction
Morbidity
Bacteria
Lipids
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

From plaque biology to clinical setting. / Arbustini, E.; Morbini, P.; Dal Bello, B.; Prati, F.; Specchia, G.

In: American Heart Journal, Vol. 138, No. 2 II, 1999.

Research output: Contribution to journalArticle

Arbustini, E. ; Morbini, P. ; Dal Bello, B. ; Prati, F. ; Specchia, G. / From plaque biology to clinical setting. In: American Heart Journal. 1999 ; Vol. 138, No. 2 II.
@article{73f55fc154d04ada956a1abdf4176887,
title = "From plaque biology to clinical setting",
abstract = "Coronary atherosclerosis may cause acute and chronic ischemic syndromes; the former are caused by 'acute plaque events,' mostly thrombosis complicating vulnerable ruptured plaques, namely severe lesions with large core, thin cap, and weak shoulder infiltrated by activated inflammatory cells. Plaque rupture may also occur in nonischemic settings and is not obligatorily complicated by thrombosis. Furthermore, plaque rupture is not the only thrombus substrate in acute ischemic syndromes: Superficial erosion of fibrous plaques is found in 44{\%} of acute thrombi in sudden coronary deaths and in 25{\%} of those in acute myocardial infarctions. Coronary thrombosis appears to be triggered by superficial intimal inflammation in plaque ulceration and by neointimal hyperplasia in plaque erosion. 'Endogenous' and, recently, exogenous factors, particularly infective intracellUlar organisms, have been proposed as major contributors to plaque inflammation, activation, and vulnerability. Possible exogenous triggers are DNA and RNA viruses and intracellular bacteria such as Chlamydia pneumoniae, which has been identified with microbiological, ultrastructural, immunohistochemical, and molecular tools in a consistent proportion of human plaque samples. Chlamydia increases local thrombogenicity and is associated with an atherogenic lipid profile. Systemic indexes of inflammation, such as PCR, SAA, and fibrinogen, are also increased in acute syndromes and common infectious diseases with high morbidity and minimal clinical impact are good candidates; Helicobacter pylori is a major one. Infectious agents could link local and systemic inflammation: White cells infected in its target tissue could circulate into the flow and be captured, on a specific local trigger, into vessel walls thus stimulating local inflammation.",
author = "E. Arbustini and P. Morbini and {Dal Bello}, B. and F. Prati and G. Specchia",
year = "1999",
doi = "10.1016/S0002-8703(99)70321-2",
language = "English",
volume = "138",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "2 II",

}

TY - JOUR

T1 - From plaque biology to clinical setting

AU - Arbustini, E.

AU - Morbini, P.

AU - Dal Bello, B.

AU - Prati, F.

AU - Specchia, G.

PY - 1999

Y1 - 1999

N2 - Coronary atherosclerosis may cause acute and chronic ischemic syndromes; the former are caused by 'acute plaque events,' mostly thrombosis complicating vulnerable ruptured plaques, namely severe lesions with large core, thin cap, and weak shoulder infiltrated by activated inflammatory cells. Plaque rupture may also occur in nonischemic settings and is not obligatorily complicated by thrombosis. Furthermore, plaque rupture is not the only thrombus substrate in acute ischemic syndromes: Superficial erosion of fibrous plaques is found in 44% of acute thrombi in sudden coronary deaths and in 25% of those in acute myocardial infarctions. Coronary thrombosis appears to be triggered by superficial intimal inflammation in plaque ulceration and by neointimal hyperplasia in plaque erosion. 'Endogenous' and, recently, exogenous factors, particularly infective intracellUlar organisms, have been proposed as major contributors to plaque inflammation, activation, and vulnerability. Possible exogenous triggers are DNA and RNA viruses and intracellular bacteria such as Chlamydia pneumoniae, which has been identified with microbiological, ultrastructural, immunohistochemical, and molecular tools in a consistent proportion of human plaque samples. Chlamydia increases local thrombogenicity and is associated with an atherogenic lipid profile. Systemic indexes of inflammation, such as PCR, SAA, and fibrinogen, are also increased in acute syndromes and common infectious diseases with high morbidity and minimal clinical impact are good candidates; Helicobacter pylori is a major one. Infectious agents could link local and systemic inflammation: White cells infected in its target tissue could circulate into the flow and be captured, on a specific local trigger, into vessel walls thus stimulating local inflammation.

AB - Coronary atherosclerosis may cause acute and chronic ischemic syndromes; the former are caused by 'acute plaque events,' mostly thrombosis complicating vulnerable ruptured plaques, namely severe lesions with large core, thin cap, and weak shoulder infiltrated by activated inflammatory cells. Plaque rupture may also occur in nonischemic settings and is not obligatorily complicated by thrombosis. Furthermore, plaque rupture is not the only thrombus substrate in acute ischemic syndromes: Superficial erosion of fibrous plaques is found in 44% of acute thrombi in sudden coronary deaths and in 25% of those in acute myocardial infarctions. Coronary thrombosis appears to be triggered by superficial intimal inflammation in plaque ulceration and by neointimal hyperplasia in plaque erosion. 'Endogenous' and, recently, exogenous factors, particularly infective intracellUlar organisms, have been proposed as major contributors to plaque inflammation, activation, and vulnerability. Possible exogenous triggers are DNA and RNA viruses and intracellular bacteria such as Chlamydia pneumoniae, which has been identified with microbiological, ultrastructural, immunohistochemical, and molecular tools in a consistent proportion of human plaque samples. Chlamydia increases local thrombogenicity and is associated with an atherogenic lipid profile. Systemic indexes of inflammation, such as PCR, SAA, and fibrinogen, are also increased in acute syndromes and common infectious diseases with high morbidity and minimal clinical impact are good candidates; Helicobacter pylori is a major one. Infectious agents could link local and systemic inflammation: White cells infected in its target tissue could circulate into the flow and be captured, on a specific local trigger, into vessel walls thus stimulating local inflammation.

UR - http://www.scopus.com/inward/record.url?scp=0032807365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032807365&partnerID=8YFLogxK

U2 - 10.1016/S0002-8703(99)70321-2

DO - 10.1016/S0002-8703(99)70321-2

M3 - Article

C2 - 10426860

AN - SCOPUS:0032807365

VL - 138

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 2 II

ER -